Showing 271-280 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Enhancing Functional Maturation of Stem Cell-Derived Beta Cells Using Harmine for Improved Diabetes Therapy Icahn School of Medicine at Mount Sinai Peng Wang Cures 01-July-2025 to 30-June-2026 $305,000.00
Protective Genetic and Pharmacological Interventions to Prevent Cytokine and Autoimmune-based Destruction of β cells. Icahn School of Medicine at Mount Sinai Romina Bevacqua Cures 01-April-2025 to 31-March-2027 $559,996.54
Cardiotoxic Circulating Extracellular Vesicles: New Drivers of Type 1 Diabetes-induced Cardiomyopathy Icahn School of Medicine at Mount Sinai Susmita Sahoo Improving Lives 01-April-2025 to 31-March-2026 $199,998.24
Development and Preclinical Assessment of a Biovascular Pancreas Humacyte Kaleb Naegeli Cures 01-April-2023 to 31-March-2026 $800,000.00
Goals of Care Among Caregivers of Youth with T1D Using The 3-Act Model Hugo W. Moser Research Institute at Kennedy Krieger Karen Dimentstein Transportfolio 01-September-2024 to 31-August-2026 $130,000.00
Advanced Oxygen Generator for Oxygenated Cell Capsules Giner, Inc. Linda Tempelman Cures 01-June-2021 to 31-December-2025 $448,173.29
Synthetic Hydrogels for Islet Vascularization and Engraftment Georgia Tech Research Corporation Andres Garcia Cures 01-July-2022 to 30-June-2026 $563,235.05
A Novel Magnetorheological Insulin Pump Georgia Southern University Research and Service Foundation, Inc Sevki Cesmeci Improving Lives 01-June-2023 to 31-May-2026 $199,516.50
Using genetics to better diagnose and treat adult-onset T1D in multi-ethnic US population Geisinger Clinic David Carey Cures 01-November-2022 to 31-October-2025 $1,469,640.10
Development of a new nanotechnology for immune-tolerizing therapy against T1D EVOQ Therapeutics, Inc. Vishalakshi Krishnan Cures 01-September-2022 to 28-February-2026 $1,110,000.00